Fulgent Genetics, Inc. (FLGT)
FLGT moved a median of +0.04% 30 minutes after news, and -0.07% by the close. How FLGT actually reacts to news — the realized, point-in-time move the market made, measured across 393 labeled events over the last three years with zero look-ahead.
FLGT’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 45% | 389 |
| 30-min | +0.04% | 51% | 393 |
| 60-min | +0.09% | 53% | 393 |
| to close | -0.07% | 47% | 393 |
| Middle 50% of FLGT reactions | -0.79% to +0.85% |
|---|---|
| Median reaction (30-min) | +0.04% |
| Measured reactions | 393 |
Half of all Fulgent Genetics, Inc. news events land between -0.79% and +0.85% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when FLGT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to FLGT's baseline. Nothing else.
Recent FLGT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-Q Fulgent Genetics, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.42% | -3.83% | |
| Form 8-K Fulgent Genetics, Inc. For: Jul 30 | SEC filing · Form 8-K | SEC EDGAR | +1.42% | -3.83% | |
| Fulgent Reports Second Quarter 2026 Financial Results | Press release | Business Wire | +1.42% | -3.83% | |
| Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 | Press release | Business Wire | -0.33% | -2.00% | |
| Form 8-K Fulgent Genetics, Inc. For: Jun 01 | SEC filing · Form 8-K | SEC EDGAR | -0.72% | +3.43% | |
| Fulgent Presents Updated FID-007 Data at ASCO 2026 | Press release | Business Wire | -0.72% | +3.43% | |
| Form 8-K Fulgent Genetics, Inc. For: May 21 | SEC filing · Form 8-K | SEC EDGAR | -0.87% | -1.27% | |
| Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting | Press release | Business Wire | -0.87% | -1.27% | |
| Form 8-K Fulgent Genetics, Inc. For: May 14 | SEC filing · Form 8-K | SEC EDGAR | +0.16% | -1.94% | |
| Form S-8 Fulgent Genetics, Inc. | SEC filing · Form S-8 | SEC EDGAR | +0.16% | -1.94% | |
| Foundation Medicine to Launch FoundationOne®PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics | Press release | Business Wire | +8.80% | +6.86% | |
| Form 10-Q Fulgent Genetics, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.55% | -3.09% | |
| Form 8-K Fulgent Genetics, Inc. For: May 01 | SEC filing · Form 8-K | SEC EDGAR | -1.03% | -3.35% | |
| Fulgent Reports First Quarter 2026 Financial Results | Press release | Business Wire | +6.77% | +0.64% | |
| Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting | Press release | Business Wire | +0.06% | -2.32% | |
| Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026 | Press release | Business Wire | +0.46% | -0.25% | |
| Form ARS Fulgent Genetics, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.25% | +2.81% | |
| Form DEF 14A Fulgent Genetics, Inc. For: Mar 31 | SEC filing · Form DEF | SEC EDGAR | -0.25% | +2.81% | |
| Form DEFA14A Fulgent Genetics, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -0.25% | +2.81% | |
| Form 8-K Fulgent Genetics, Inc. For: Mar 17 | SEC filing · Form 8-K | SEC EDGAR | +1.98% | -1.82% | |
| Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx | Press release | Business Wire | +1.98% | -1.82% | |
| Form 10-K Fulgent Genetics, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -3.70% | -17.71% | |
| Form 8-K Fulgent Genetics, Inc. For: Feb 27 | SEC filing · Form 8-K | SEC EDGAR | -3.70% | -17.71% | |
| Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | Business Wire | -3.70% | -17.71% | |
| Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 | Press release | Business Wire | +1.34% | -0.73% | |
| Form 8-K Fulgent Genetics, Inc. For: Dec 20 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.59% | |
| Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx | Press release | Business Wire | +0.00% | -0.59% | |
| Form 10-Q Fulgent Genetics, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +13.31% | +9.65% | |
| Form 8-K Fulgent Genetics, Inc. For: Nov 07 | SEC filing · Form 8-K | SEC EDGAR | +13.31% | +9.65% | |
| Fulgent Reports Third Quarter 2025 Financial Results | Press release | Business Wire | +13.31% | +9.65% | |
| Fulgent to Participate in Upcoming Conferences | Press release | Business Wire | +0.84% | +1.19% | |
| Form 8-K Fulgent Genetics, Inc. For: Oct 20 | SEC filing · Form 8-K | SEC EDGAR | +0.37% | +4.24% | |
| Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference | Press release | Business Wire | +0.37% | +4.24% | |
| Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025 | Press release | Business Wire | +0.83% | -0.57% | |
| Form 10-Q Fulgent Genetics, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.14% | -3.74% | |
| Form 8-K Fulgent Genetics, Inc. For: Aug 01 | SEC filing · Form 8-K | SEC EDGAR | -3.14% | -3.74% | |
| Fulgent Reports Second Quarter 2025 Financial Results | Press release | Business Wire | -3.14% | -3.74% | |
| Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM | Press release | Business Wire | +0.53% | +0.33% | |
| Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025 | Press release | Business Wire | -0.34% | -0.82% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +0.51% | +0.16% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.72% | +1.66% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.51% | +0.79% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.07% | -0.14% | |
| Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.37% | +2.73% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulgent Genetics, Inc. (FLGT) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | +0.49% | +2.32% | |
| Fulgent Genetics, Inc. (FLGT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.58% | +0.19% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.13% | +3.01% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Fulgent Genetics, Inc. (FLGT) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.63% | -1.80% | |
| Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc | Press release | PR Newswire | +1.85% | +5.99% | |
| Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc | Press release | GlobeNewswire | +0.15% | +1.70% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the FLGT section they belong to.
Where else FLGT is measured.
FLGT earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | 395 | -0.21% | 45% |
| Axogen, Inc. (AXGN) | 393 | -0.12% | 48% |
| Kazia Therapeutics Limited - American Depositary Shares (KZIA) | 393 | -1.07% | 34% |
| OHR PHARMACEUTICALS (OHRP) | 393 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Fulgent Genetics, Inc.'s median reaction calculated?
Every labeled FLGT news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 393 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of FLGT's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does FLGT's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.